封面
市場調查報告書
商品編碼
1168301

生物催化劑的全球市場:展望與預測(2022年~2027年)

Biocatalysts Market - Global Outlook & Forecast 2022-2027

出版日期: | 出版商: Arizton Advisory & Intelligence | 英文 238 Pages | 訂單完成後即時交付

價格

全球生物催化劑的市場規模,2021年~2027年之間預計以5.60%的年複合成長率成長。

對生物為基礎產品的需求高漲,促進生物催化劑市場。由於新技術的出現永續性在全球高漲,製藥產業,為了提高產品品質,企業開始使用生物為基礎藥物,讓製藥用生物催化劑市場急速成長。還有主要企業,為了獲得更大的生物催化劑的市場佔有率推動擴張策略。此外,在食品、飲料產業,由於食品、飲料的消費增加擴大,全球產業的生物催化劑的需求增大。

本報告提供全球生物催化劑市場相關調查分析,市場概要,趨勢,各市場區隔、各地區的市場分析,競爭情形,企業簡介等系統性資訊。

目錄

第1章 調查手法

第2章 調查目的

第3章 調查流程

第4章 適用範圍

  • 市場定義
    • 蘊藏事項
    • 除外事項
    • 市場預測相關注意事項
  • 基準年
  • 調查範圍
    • 市場明細:各地區

第5章 報告的前提條件與注意事項

  • 主要的注意事項
  • 貨幣換算
  • 市場誘導

第6章 重要考察

  • 簡介
  • 市場摘要
    • 促進因素
    • 機會
    • 阻礙因素
  • 市場區隔檢討
    • 終端用戶
    • 類型
  • 地區
  • 企業與策略

第7章 市場概要

第8章 簡介

  • 概要
  • 價值鏈分析
    • 原料
    • 生物催化劑廠商
    • 批發商
    • 用途
  • 宏觀經濟要素
    • 醫藥品、生物醫藥品產業
    • 食品、飲料產業

第9章 市場機會及趨勢

  • 製藥產業的需求增加
  • 生質燃料需求的劇增
  • 為了改善生產率和盈利的永續性標準的採用
  • 清洗劑的使用擴大

第10章 促進市場成長因素

  • 人口增加的食品消費增加
  • 植物來源產品的需求高漲

第11章 阻礙市場成長要素

  • 生物催化劑影響市場的技術性障礙
  • 高成本和生物為基礎產品的認識不足

第12章 市場形勢

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析
    • 新加入業者的威脅
    • 供給企業談判力
    • 買方議價能力
    • 替代品的威脅
    • 競爭企業間的敵對關係

第13章 類型

  • 市場概述與成長促進因素
  • 市場概要
  • 碳水化合物分解酵素
  • 蛋白分解酵素
  • 聚合酵素和核酸水解酵素
  • 解脂酵素
  • 植酸酵素
  • 其他

第14章 終端用戶

  • 市場概述與成長促進因素
  • 市場概要
  • 醫藥品
  • 食品、飲料
  • 動物營養
  • 家用品
  • 其他

第15章 地區

  • 市場概述與成長促進因素
  • 地區概要

第16章 北美

  • 市場概要
  • 市場規模與預測
  • 類型
  • 終端用戶
  • 主要國家
  • 美國
  • 加拿大

第17章 歐洲

  • 市場概要
  • 市場規模與預測
  • 類型
  • 終端用戶
  • 主要國家
  • 德國
  • 法國
  • 義大利
  • 西班牙
  • 其他歐洲

第18章 亞太地區

  • 市場概要
  • 市場規模與預測
  • 類型
  • 終端用戶
  • 主要國家
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區

第19章 中東、非洲

  • 市場概要
  • 市場規模與預測
  • 類型
  • 終端用戶
  • 主要國家
  • 沙烏地阿拉伯
  • 南非
  • 其他中東、非洲

第20章 南美

  • 市場概要
  • 市場規模與預測
  • 類型
  • 終端用戶
  • 主要國家
  • 巴西
  • 墨西哥
  • 其他南美國家

第21章 競爭情形

  • 競爭概要

第22章 主要企業簡介

  • DUPONT
  • BASF SE
  • DSM
  • AB ENZYMES
  • NOVOZYMES

第23章 其他的著名供應商

第24章 報告概要

  • 重要點
  • 策略性推薦事項

第25章 定量的摘要

第26章 地區

第27章 附錄

Product Code: ARZ220931

The global biocatalysts market is expected to grow at a CAGR of 5.60% during 2021-2027.

MARKET SYNOPSIS

Biocatalysts are substances, specifically enzymes, that activate or speed up a biochemical reaction. Biocatalysts are used in chemical synthesis in various industries (such as pharmaceuticals, food & beverages, animal nutrition, household, and others). In the pharmaceutical industry, biocatalysts help in manufacturing drugs for DNA/RNA treatment, cancer, heart-related disease, and other treatments.

Increasing demand for biobased products drives the biocatalysts market. Due to emerging technology, sustainability is growing all over the world. In the pharmaceutical industry, companies have started using biobased drugs to improve the quality of products, making the pharmaceutical biocatalysts market grow rapidly. Thus, top companies follow the expansion strategy for acquiring a greater biocatalysts market share. The food & beverages industry is rising due to the increasing consumption of food & beverages, thus increasing the demand for biocatalysts in the global industry.

MARKET TRENDS & DRIVERS

Increase in Food Consumption Due to Growth in Population

  • The food industry includes four major sectors - producers, marketers, processors, and farm services. During the Covid 19, the demand for food supplies increased, resulting in the food industry's growth. Enzymes are used in the food industry as a preservative, the best substitute for chemical preservatives. They improve the quality of products such as starch, fruit juices, cheese, animal feed, and beer & wine. From the application perspective, the demand for animal feed is increasing due to higher poultry, meat, and dairy consumption.

Increasing Demand from Pharmaceutical Industry

  • The pharmaceutical industry's revenue is increasing yearly due to increasing demand for the drugs used for manufacturing pharmaceutical products. In past years, the Chinese pharma industry has been on the top in terms of growth rate. The consumption of pharmaceutical products is growing due to changes in clinical practices and increasing chronic and aging-related issues.
  • The lowering of regulatory barriers for new drugs in the US causes an increased demand for pharma sector products globally. During the Covid-19 pandemic, the highest demand for pharmaceutical products was observed. The demand for new drugs is still high owing to the recurrence of new variants of Covid-19 in various countries. The demand for pharmaceutical products is also increasing in developing countries such as India, China, and Brazil, among others owing to the emergence of Covid-19 variants, lifestyle diseases, and an aging population. Biocatalysts are used in the manufacturing processes of antibiotics to treat such diseases. And with a growing global pharmaceutical industry, the biocatalysts market is also growing.

MARKET RESTRAINT

Technical Barriers Affecting Industry

  • Biocatalysis is a process that accelerates the chemical process by using biomolecules. It includes mild reaction and high selectivity conditions. Therefore, biocatalysts play an important role in the chemical industry and are gaining relevance in industrial applications. But, there is difficulty in finding the accurate protein structure of biocatalysts. The process is time-consuming and requires more catalysts to fulfilling the chemical reaction process. For the biocatalysts manufacturing process, specific conditions such as new substrate, new concentration, and other conditions are required which are not found easily in nature. Thus, increasing the cost of producing the biocatalysts.

SEGMENTATION ANALYSIS

INSIGHTS BY TYPE

  • Carbohydrases is the largest segment by type in the global biocatalysts market and is expected to reach USD 231.03 million by 2027. Carbohydrases are mainly used in the food industry as biocatalysts. Most of these biocatalysts used in the food industry are produced from fungi, yeast, and bacteria. Carbohydrases are used in milk products as digestion agents to reduce milk lactose. These are further classified into alpha, beta amylases, cellulases, glucosidase, pectinases, mannanases, galacto, and pullulanase.
  • The global proteases-based biocatalysts market was valued at USD 134.40 million in 2021 and is the second largest industry by type segment. The proteases are used in the cleaning, leather, and dairy industries. Based on the catalysis mechanism, the proteases are classified into further classes glutamic, aspartic, metalloproteases, threonine, cysteine, and serine proteases which activate the water molecule and attack the proteins.
  • Lipases are used in the catalysis of fats, which helps reduce their food content. These are derived from animal and plant enzymes used in various biological processes, which are used for inflammation, diet, and increasing metabolism. The lipases segment is expected to grow at a CAGR of 5.49% during the forecast period. These are used in esters and have high scope in biofuels. The increased demand for biofuels is due to the increasing prices of crude oil, which further increases the demand for lipases in the biocatalysts markets.

Segmentation by Type

  • Carbohydrases
  • Proteases
  • Polymerases & Nucleases
  • Lipases
  • Phytases
  • Other

INSIGHTS BY END-USE

  • The global biocatalysts market by end-use is categorized as pharmaceutical, food & beverages, animal nutrition, household, and others. The pharmaceutical is the largest segment by end-use and is expected to cross USD 215.42 million by 2027. Due to growth in the global population, the demand for pharmaceutical products is increasing. Due to which people are becoming more health conscious, pharmaceutical companies are focusing on increasing the bio-based content in drug formulations. In the pharmaceutical industry, biocatalysts are used for molecular biology, extraction of medically important compounds, diagnostic procedures, chemical pharmaceutical manufacturing, and deficiencies supplements.
  • The food & beverages segment is growing with a CAGR of 6.31 % during the forecast period and is the second largest segment by end-use. Biocatalysts have been used for hundreds of years in the food & beverages industry. Commercial biocatalysts are produced from microbial, plants, and animals. There is a massive demand for bakery biocatalysts in the industry for extending shelf life, mainly in Europe and North America. Biocatalyst manufacturing companies are developing new designs to improve bakery food quality.

Segmentation by End Use

  • Pharmaceutical
  • Food & Beverages
  • Animal Nutrition
  • Household
  • Others

GEOGRAPHICAL ANALYSIS

North America dominates the global biocatalysts market and is expected to grow at a CAGR of 6.27% during the forecast period. The region is the leading market for biocatalysts because of its rapidly developing infrastructure, readily increasing population, and growing demand from various industries such as food & beverage, pharmaceutical, animal nutrition, and household. The US and Canada are the two major countries dominating North America's biocatalyst market. The demand for biocatalysts in North America's pharmaceutical industry is increasing with the rise in pharma products and the presence of the world-leading ten pharmaceutical companies in the US.

APAC biocatalysts market is the second largest industry globally and is expected to grow the highest CAGR during the forecast period. With the changing technology & innovations in food & beverages, the demand for biocatalysts is increasing. Increasing health expenditure, increasing health consciousness, increasing new diseases, and others are the key factors for the growing pharmaceutical market, further contributing to the Asia Pacific industry.

Germany, Italy, France, and Spain are the major countries in the European biocatalyst market. The increasing consumption of biocatalysts is attributed to the rising per capita income in European countries. High spending on healthy food, attributed to people's health-conscious habits, and growing demand for food & beverages biocatalysts are significant market drivers in Europe.

Segmentation by Geography

  • APAC
    • China
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • North America
    • US
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • Italy
    • Rest of Europe
  • Latin America
    • Brazil
    • Mexico
    • Rest Of Latin America
  • Middle East & Africa
    • South Africa
    • South Arabia
    • Rest of the Middle East & Africa

VENDOR LANDSCAPE

Some key players in the global biocatalysts market include DuPont (U.S.), AB Enzymes (Germany), BASF SE (Germany), Novozymes (Denmark), and DSM (Netherlands). These players have adopted strategies such as expansion, acquisitions, new product development, joint ventures, and others to increase their revenues in the biocatalysts market. Furthermore, other prominent companies such as Amano Enzymes (Japan), Dyadic International (U.S.), Codexis (U.S.), and others have invested considerable capital in R&D to develop biocatalysts-based products that will appeal to the customers. Therefore, these other prominent companies are giving tough competition to major companies.

The major companies follow a merger and acquisition strategy, giving them a competitive advantage to boost their market share. The key vendors have undertaken various strategies to grow in the global biocatalysts market. The growth in sustainable processes and innovations has challenged all companies globally. Investments in R&D, technological advancement, and environmental and economic challenges drive the demand for innovative and sustainable biocatalysts products.

Key Vendors

  • DuPont
  • BASF SE
  • DSM
  • AB Enzymes
  • Novozymes

Other Prominent Vendors

  • Chr Hansen Holding A/S
  • Codexis
  • Dyadic International Inc.
  • Amano Enzymes
  • Biocatalysts
  • Nature Bioscience Pvt Ltd.
  • Johnson Matthey
  • Advanced Enzymes Technologies
  • Zymtronix, Inc.
  • Nutritech
  • Hoffmann-La Roche Ltd (Roche CustomBiotech)
  • Aumenzymes
  • The Soufflet Group
  • Iosynth

Key Developments In The Global Biocatalysts Market:

  • In 2021 Novozymes bought majority stakes in the Mumbai (India) based Synergia Life Sciences company, a global leader in the microbiome therapeutic and vitamin k2-7 manufacturer and supplier.
  • DSM acquired the U.S.-based First Choice Ingredients company, a manufacturer of dairy-based flavorings. This deal gives the company fermentation and biotechnology solutions.

KEY QUESTIONS ANSWERED

  • 1. What is the revenue from the global biocatalysts market?
  • 2. What is the growth rate of the biocatalysts market?
  • 3. Who are the key players in the global biocatalysts market?
  • 4. What is the projected biocatalysts market by 2027?
  • 5. What are the key driving factors in the global biocatalysts market?
  • 6. Which region dominates the global biocatalysts Market?

TABLE OF CONTENTS

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

  • 4.1 MARKET DEFINITION
    • 4.1.1 INCLUSIONS
    • 4.1.2 EXCLUSIONS
    • 4.1.3 MARKET ESTIMATION CAVEATS
  • 4.2 BASE YEAR
  • 4.3 SCOPE OF THE STUDY
    • 4.3.1 MARKET SEGMENTATION BY GEOGRAPHY

5 REPORT ASSUMPTIONS & CAVEATS

  • 5.1 KEY CAVEATS
  • 5.2 CURRENCY CONVERSION
  • 5.3 MARKET DERIVATION

6 PREMIUM INSIGHTS

  • 6.1 INTRODUCTION
  • 6.2 MARKET SYNOPSIS
    • 6.2.1 ENABLER
    • 6.2.2 OPPORTUNITIES
    • 6.2.3 RESTRAINT
  • 6.3 SEGMENT REVIEW
    • 6.3.1 END-USERS
    • 6.3.2 TYPE
  • 6.4 GEOGRAPHY
  • 6.5 COMPANIES AND STRATEGIES

7 MARKET AT A GLANCE

8 INTRODUCTION

  • 8.1 OVERVIEW
  • 8.2 VALUE CHAIN ANALYSIS
    • 8.2.1 RAW MATERIALS
    • 8.2.2 BIOCATALYST MANUFACTURER
    • 8.2.3 DISTRIBUTOR
    • 8.2.4 APPLICATION
  • 8.3 MACROECONOMIC FACTORS
    • 8.3.1 PHARMACEUTICAL & BIOPHARMACEUTICAL INDUSTRIES
    • 8.3.2 FOOD & BEVERAGES INDUSTRY

9 MARKET OPPORTUNITIES & TRENDS

  • 9.1 INCREASING DEMAND FROM PHARMACEUTICAL INDUSTRY
  • 9.2 SOARING DEMAND FOR BIOFUEL
  • 9.3 ADOPTION OF SUSTAINABILITY STANDARDS TO IMPROVE PRODUCTIVITY & PROFITABILITY
  • 9.4 INCREASING USE OF CLEANING PRODUCTS

10 MARKET GROWTH ENABLERS

  • 10.1 INCREASE IN FOOD CONSUMPTION DUE TO GROWING POPULATION
  • 10.2 RISE IN DEMAND FOR PLANT-BASED PRODUCTS

11 MARKET GROWTH RESTRAINTS

  • 11.1 TECHNICAL BARRIERS AFFECTING BIOCATALYSTS MARKET
  • 11.2 HIGH COST & LACK OF AWARENESS OF BIOBASED PRODUCTS

12 MARKET LANDSCAPE

  • 12.1 MARKET OVERVIEW
  • 12.2 MARKET SIZE & FORECAST
  • 12.3 FIVE FORCES ANALYSIS
    • 12.3.1 THREAT OF NEW ENTRANTS
    • 12.3.2 BARGAINING POWER OF SUPPLIERS
    • 12.3.3 BARGAINING POWER OF BUYERS
    • 12.3.4 THREAT OF SUBSTITUTES
    • 12.3.5 COMPETITIVE RIVALRY

13 TYPE

  • 13.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 13.2 MARKET OVERVIEW
  • 13.3 CARBOHYDRASES
    • 13.3.1 MARKET OVERVIEW
    • 13.3.2 MARKET SIZE & FORECAST
    • 13.3.3 MARKET BY GEOGRAPHY
  • 13.4 PROTEASES
    • 13.4.1 MARKET OVERVIEW
    • 13.4.2 MARKET SIZE & FORECAST
    • 13.4.3 MARKET BY GEOGRAPHY
  • 13.5 POLYMERASES & NUCLEASES
    • 13.5.1 MARKET OVERVIEW
    • 13.5.2 MARKET SIZE & FORECAST
    • 13.5.3 MARKET BY GEOGRAPHY
  • 13.6 LIPASES
    • 13.6.1 MARKET OVERVIEW
    • 13.6.2 MARKET SIZE & FORECAST
    • 13.6.3 MARKET BY GEOGRAPHY
  • 13.7 PHYTASES
    • 13.7.1 MARKET OVERVIEW
    • 13.7.2 MARKET SIZE & FORECAST
    • 13.7.3 MARKET BY GEOGRAPHY
  • 13.8 OTHERS
    • 13.8.1 MARKET OVERVIEW
    • 13.8.2 MARKET SIZE & FORECAST
    • 13.8.3 MARKET BY GEOGRAPHY

14 END-USER

  • 14.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 14.2 MARKET OVERVIEW
  • 14.3 PHARMACEUTICAL
    • 14.3.1 MARKET OVERVIEW
    • 14.3.2 MARKET SIZE & FORECAST
    • 14.3.3 MARKET BY GEOGRAPHY
  • 14.4 FOOD & BEVERAGES
    • 14.4.1 MARKET OVERVIEW
    • 14.4.2 MARKET SIZE & FORECAST
    • 14.4.3 MARKET BY GEOGRAPHY
  • 14.5 ANIMAL NUTRITION
    • 14.5.1 MARKET OVERVIEW
    • 14.5.2 MARKET SIZE & FORECAST
    • 14.5.3 MARKET BY GEOGRAPHY
  • 14.6 HOUSEHOLD
    • 14.6.1 MARKET OVERVIEW
    • 14.6.2 MARKET SIZE & FORECAST
    • 14.6.3 MARKET BY GEOGRAPHY
  • 14.7 OTHERS
    • 14.7.1 MARKET OVERVIEW
    • 14.7.2 MARKET SIZE & FORECAST
    • 14.7.3 MARKET BY GEOGRAPHY

15 GEOGRAPHY

  • 15.1 MARKET SNAPSHOT & GROWTH ENGINE
  • 15.2 GEOGRAPHIC OVERVIEW

16 NORTH AMERICA

  • 16.1 MARKET OVERVIEW
  • 16.2 MARKET SIZE & FORECAST
  • 16.3 TYPE
    • 16.3.1 MARKET SIZE & FORECAST
  • 16.4 END-USER
    • 16.4.1 MARKET SIZE & FORECAST
  • 16.5 KEY COUNTRIES
  • 16.6 US
    • 16.6.1 MARKET SIZE & FORECAST
  • 16.7 CANADA
    • 16.7.1 MARKET SIZE & FORECAST

17 EUROPE

  • 17.1 MARKET OVERVIEW
  • 17.2 MARKET SIZE & FORECAST
  • 17.3 TYPE
    • 17.3.1 MARKET SIZE & FORECAST
  • 17.4 END-USER
    • 17.4.1 MARKET SIZE & FORECAST
  • 17.5 KEY COUNTRIES
  • 17.6 GERMANY
    • 17.6.1 MARKET SIZE & FORECAST
  • 17.7 FRANCE
    • 17.7.1 MARKET SIZE & FORECAST
  • 17.8 ITALY
    • 17.8.1 MARKET SIZE & FORECAST
  • 17.9 SPAIN
    • 17.9.1 MARKET SIZE & FORECAST
  • 17.10 REST OF EUROPE
    • 17.10.1 MARKET SIZE & FORECAST

18 APAC

  • 18.1 MARKET OVERVIEW
  • 18.2 MARKET SIZE & FORECAST
  • 18.3 TYPE
    • 18.3.1 MARKET SIZE & FORECAST
  • 18.4 END-USER
    • 18.4.1 MARKET SIZE & FORECAST
  • 18.5 KEY COUNTRIES
  • 18.6 CHINA
    • 18.6.1 MARKET SIZE & FORECAST
  • 18.7 INDIA
    • 18.7.1 MARKET SIZE & FORECAST
  • 18.8 JAPAN
    • 18.8.1 MARKET SIZE & FORECAST
  • 18.9 SOUTH KOREA
    • 18.9.1 MARKET SIZE & FORECAST
  • 18.10 REST OF APAC
    • 18.10.1 MARKET SIZE & FORECAST

19 MIDDLE EAST & AFRICA

  • 19.1 MARKET OVERVIEW
  • 19.2 MARKET SIZE & FORECAST
  • 19.3 TYPE
    • 19.3.1 MARKET SIZE & FORECAST
  • 19.4 END-USER
    • 19.4.1 MARKET SIZE & FORECAST
  • 19.5 KEY COUNTRIES
  • 19.6 SAUDI ARABIA
    • 19.6.1 MARKET SIZE & FORECAST
  • 19.7 SOUTH AFRICA
    • 19.7.1 MARKET SIZE & FORECAST
  • 19.8 REST OF MIDDLE EAST & AFRICA
    • 19.8.1 MARKET SIZE & FORECAST

20 LATIN AMERICA

  • 20.1 MARKET OVERVIEW
  • 20.2 MARKET SIZE & FORECAST
  • 20.3 TYPE
    • 20.3.1 MARKET SIZE & FORECAST
  • 20.4 END-USER
    • 20.4.1 MARKET SIZE & FORECAST
  • 20.5 KEY COUNTRIES
  • 20.6 BRAZIL
    • 20.6.1 MARKET SIZE & FORECAST
  • 20.7 MEXICO
    • 20.7.1 MARKET SIZE & FORECAST
  • 20.8 REST OF LATIN AMERICA
    • 20.8.1 MARKET SIZE & FORECAST

21 COMPETITIVE LANDSCAPE

  • 21.1 COMPETITION OVERVIEW

22 KEY COMPANY PROFILES

  • 22.1 DUPONT
    • 22.1.1 BUSINESS OVERVIEW
    • 22.1.2 FINANCIAL OVERVIEW
    • 22.1.3 PRODUCT OFFERINGS
    • 22.1.4 KEY STRATEGIES
    • 22.1.5 KEY STRENGTHS
    • 22.1.6 KEY OPPORTUNITIES
  • 22.2 BASF SE
    • 22.2.1 BUSINESS OVERVIEW
    • 22.2.2 FINANCIAL OVERVIEW
    • 22.2.3 PRODUCT OFFERINGS
    • 22.2.4 KEY STRATEGIES
    • 22.2.5 KEY STRENGTHS
    • 22.2.6 KEY OPPORTUNITY
  • 22.3 DSM
    • 22.3.1 BUSINESS OVERVIEW
    • 22.3.2 FINANCIAL OVERVIEW
    • 22.3.3 PRODUCT OFFERINGS
    • 22.3.4 KEY STRATEGY
    • 22.3.5 KEY STRENGTHS
    • 22.3.6 KEY OPPORTUNITY
  • 22.4 AB ENZYMES
    • 22.4.1 BUSINESS OVERVIEW
    • 22.4.2 FINANCIAL OVERVIEW
    • 22.4.3 PRODUCT OFFERINGS
    • 22.4.4 KEY STRATEGIES
    • 22.4.5 KEY STRENGTHS
    • 22.4.6 KEY OPPORTUNITIES
  • 22.5 NOVOZYMES
    • 22.5.1 BUSINESS OVERVIEW
    • 22.5.2 FINANCIAL OVERVIEW
    • 22.5.3 PRODUCT OFFERINGS
    • 22.5.4 KEY STRATEGIES
    • 22.5.5 KEY STRENGTHS
    • 22.5.6 KEY OPPORTUNITIES

23 OTHER PROMINENT VENDORS

  • 23.1 CHR. HANSEN HOLDING A/S
    • 23.1.1 COMPANY OVERVIEW
    • 23.1.2 BUSINESS OVERVIEW
    • 23.1.3 PRODUCT OFFERINGS
  • 23.2 CODEXIS
    • 23.2.1 COMPANY OVERVIEW
    • 23.2.2 BUSINESS OVERVIEW
    • 23.2.3 PRODUCT OFFERINGS
  • 23.3 DYADIC INTERNATIONAL INC.
    • 23.3.1 COMPANY OVERVIEW
    • 23.3.2 BUSINESS OVERVIEW
    • 23.3.3 PRODUCT OFFERINGS
  • 23.4 AMANO ENZYME INC.
    • 23.4.1 COMPANY OVERVIEW
    • 23.4.2 BUSINESS OVERVIEW
    • 23.4.3 PRODUCT OFFERINGS
  • 23.5 BIOCATALYSTS
    • 23.5.1 COMPANY OVERVIEW
    • 23.5.2 BUSINESS OVERVIEW
    • 23.5.3 PRODUCT OFFERINGS
  • 23.6 NATURE BIOSCIENCE
    • 23.6.1 COMPANY OVERVIEW
    • 23.6.2 BUSINESS OVERVIEW
    • 23.6.3 PRODUCT OFFERINGS
  • 23.7 JOHNSON MATTHEY
    • 23.7.1 COMPANY OVERVIEW
    • 23.7.2 BUSINESS OVERVIEW
    • 23.7.3 PRODUCT OFFERINGS
  • 23.8 ADVANCED ENZYMES TECHNOLOGIES
    • 23.8.1 COMPANY OVERVIEW
    • 23.8.2 BUSINESS OVERVIEW
    • 23.8.3 PRODUCT OFFERINGS
  • 23.9 ZYMTRONIX, INC.
    • 23.9.1 COMPANY OVERVIEW
    • 23.9.2 PRODUCT OFFERINGS
  • 23.10 NUTRITECH
    • 23.10.1 COMPANY OVERVIEW
    • 23.10.2 PRODUCT OFFERINGS
  • 23.11 F. HOFFMANN-LA ROCHE LTD (ROCHE CUSTOMBIOTECH)
    • 23.11.1 COMPANY OVERVIEW
    • 23.11.2 BUSINESS OVERVIEW
    • 23.11.3 PRODUCT OFFERINGS
  • 23.12 AUMENZYMES
    • 23.12.1 COMPANY OVERVIEW
    • 23.12.2 PRODUCT OFFERINGS
  • 23.13 SOUFFLET GROUP
    • 23.13.1 COMPANY OVERVIEW
    • 23.13.2 BUSINESS OVERVIEW
    • 23.13.3 PRODUCT OFFERINGS
  • 23.14 IOSYNTH
    • 23.14.1 COMPANY OVERVIEW
    • 23.14.2 BUSINESS OVERVIEW
    • 23.14.3 PRODUCT OFFERINGS

24 REPORT SUMMARY

  • 24.1 KEY TAKEAWAYS
  • 24.2 STRATEGIC RECOMMENDATIONS

25 QUANTITATIVE SUMMARY

  • 25.1 MARKET BY END-USER
    • 25.1.1 PHARMACEUTICAL
    • 25.1.2 FOOD & BEVERAGE
    • 25.1.3 ANIMAL NUTRITION
    • 25.1.4 HOUSEHOLD
    • 25.1.5 OTHERS
  • 25.2 MARKET BY TYPE
    • 25.2.1 CARBOHYDRASES
    • 25.2.2 PROTEASES
    • 25.2.3 POLYMERASES & NUCLEASES
    • 25.2.4 LIPASES
    • 25.2.5 PHYTASES
    • 25.2.6 OTHER

26 GEOGRAPHY

  • 26.1 NORTH AMERICA
    • 26.1.1 TYPE
    • 26.1.2 END-USER
  • 26.2 EUROPE
    • 26.2.1 TYPE
    • 26.2.2 END-USER
  • 26.3 APAC
    • 26.3.1 TYPE
    • 26.3.2 END-USER
  • 26.4 MIDDLE EAST & AFRICA
    • 26.4.1 TYPE
    • 26.4.2 END-USER
  • 26.5 LATIN AMERICA
    • 26.5.1 TYPE
    • 26.5.2 END-USER

27 APPENDIX

  • 27.1 ABBREVIATIONS

LIST OF EXHIBITS

  • EXHIBIT 1 SEGMENTATION OF GLOBAL BIOCATALYSTS MARKET
  • EXHIBIT 2 BIOCATALYSTS MARKET SIZE CALCULATION APPROACH 2021
  • EXHIBIT 3 GLOBAL BIOCATALYSTS MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 4 GLOBAL BIOCATALYSTS MARKET BY TYPE (% SHARE)
  • EXHIBIT 5 GLOBAL BIOCATALYSTS MARKET BY REGION (% SHARE)
  • EXHIBIT 6 PROPERTIES OF BIOCATALYSTS IN CHEMICAL REACTIONS
  • EXHIBIT 7 VALUE CHAIN ANALYSIS OF BIOCATALYSTS MARKET
  • EXHIBIT 8 GEOGRAPHICAL BREAKDOWN: SALE OF NEW MEDICINES 2015-2020
  • EXHIBIT 9 PHARMACEUTICAL R&D EXPENDITURE IN EUROPE & US 1990-2019 ($ MILLION)
  • EXHIBIT 10 GLOBAL BIOPHARMACEUTICAL R&D SPENDING ($ BILLION)
  • EXHIBIT 11 IMPACT OF INCREASING DEMAND FROM PHARMACEUTICAL INDUSTRY
  • EXHIBIT 12 GLOBAL DRUG CONSUMPTION (NUMBER OF PEOPLE, $ MILLION)
  • EXHIBIT 13 IMPACT OF SOARING DEMAND FOR BIOFUEL
  • EXHIBIT 14 RISING PRICES OF CRUDE OIL PER BARREL ($)
  • EXHIBIT 15 IMPACT OF ADOPTION OF SUSTAINABILITY STANDARDS TO IMPROVE PRODUCTIVITY & PROFITABILITY
  • EXHIBIT 16 IMPACT OF INCREASING USE OF CLEANING PRODUCTS
  • EXHIBIT 17 US LAUNDRY DETERGENT SALES BY PRODUCT TYPE 2021 (MILLION UNITS)
  • EXHIBIT 18 IMPACT OF INCREASE IN FOOD CONSUMPTION DUE TO GROWING POPULATION
  • EXHIBIT 19 GLOBAL POPULATION 2016-2021 (BILLION UNITS)
  • EXHIBIT 20 IMPACT OF RISE IN DEMAND FOR PLANT-BASED PRODUCTS
  • EXHIBIT 21 PLANT-BASED FOOD SALES IN US 2020 ($ BILLION)
  • EXHIBIT 22 PLANT-BASED FOOD MARKET IN US
  • EXHIBIT 23 IMPACT OF TECHNICAL BARRIERS AFFECTING BIOCATALYSTS MARKET
  • EXHIBIT 24 CONDITIONS REQUIRED FOR ENZYMOLOGY
  • EXHIBIT 25 IMPACT OF HIGH COST & LACK OF AWARENESS OF BIOBASED PRODUCTS
  • EXHIBIT 26 DESIGNED ENZYME PRODUCTION FACILITY'S ANNUAL OPERATING COST (%)
  • EXHIBIT 27 GLOBAL BIOCATALYSTS MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 28 FIVE FORCES ANALYSIS 2021
  • EXHIBIT 29 INCREMENTAL GROWTH BY TYPE 2021 & 2027
  • EXHIBIT 30 CLASSIFICATION OF BIOCATALYSTS MARKET BASED ON TYPE
  • EXHIBIT 31 GLOBAL CARBOHYDRASES-BASED BIOCATALYSTS MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 32 GLOBAL PROTEASES-BASED BIOCATALYSTS MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 33 GLOBAL POLYMERASES & NUCLEASES BIOCATALYSTS MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 34 GLOBAL LIPASE BIOCATALYSTS MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 35 GLOBAL PHYTASE BIOCATALYSTS MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 36 GLOBAL OTHER BIOCATALYSTS MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 37 INCREMENTAL GROWTH BY END-USER 2021 & 2027
  • EXHIBIT 38 CLASSIFICATION OF BIOCATALYSTS MARKET BASED ON END-USERS
  • EXHIBIT 39 GLOBAL PHARMACEUTICAL BIOCATALYSTS MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 40 GLOBAL FOOD & BEVERAGES BIOCATALYSTS MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 41 GLOBAL ANIMAL NUTRITION BIOCATALYSTS MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 42 GLOBAL HOUSEHOLD BIOCATALYSTS MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 43 GLOBAL OTHER BIOCATALYSTS MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 44 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
  • EXHIBIT 45 GEOGRAPHIC CONTRIBUTION & ABSOLUTE GROWTH OF BIOCATALYSTS MARKET
  • EXHIBIT 46 GEOGRAPHIC OVERVIEW OF BIOCATALYSTS MARKET
  • EXHIBIT 47 NORTH AMERICA BIOCATALYSTS MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 48 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027
  • EXHIBIT 49 BIOCATALYSTS MARKET IN US 2021-2027 ($ MILLION)
  • EXHIBIT 50 BIOCATALYSTS MARKET IN CANADA 2021-2027 ($ MILLION)
  • EXHIBIT 51 BIOCATALYSTS MARKET IN EUROPE 2021-2027 ($ MILLION)
  • EXHIBIT 52 INCREMENTAL GROWTH IN EUROPE 2021 & 2027
  • EXHIBIT 53 BIOCATALYSTS MARKET IN GERMANY 2021-2027 ($ MILLION)
  • EXHIBIT 54 BIOCATALYSTS MARKET IN FRANCE 2021-2027 ($ MILLION)
  • EXHIBIT 55 BIOCATALYSTS MARKET IN ITALY 2021-2027 ($ MILLION)
  • EXHIBIT 56 BIOCATALYSTS MARKET IN SPAIN 2021-2027 ($ MILLION)
  • EXHIBIT 57 BIOCATALYSTS MARKET IN REST OF EUROPE 2021-2027 ($ MILLION)
  • EXHIBIT 58 APAC BIOCATALYSTS MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 59 INCREMENTAL GROWTH IN APAC 2021 & 2027
  • EXHIBIT 60 BIOCATALYSTS MARKET IN CHINA 2021-2027 ($ MILLION)
  • EXHIBIT 61 BIOCATALYSTS MARKET IN INDIA 2021-2027 ($ MILLION)
  • EXHIBIT 62 BIOCATALYSTS MARKET IN JAPAN 2021-2027 ($ MILLION)
  • EXHIBIT 63 BIOCATALYSTS MARKET IN SOUTH KOREA 2021-2027 ($ MILLION)
  • EXHIBIT 64 BIOCATALYSTS MARKET IN REST OF APAC 2021-2027 ($ MILLION)
  • EXHIBIT 65 MIDDLE EAST & AFRICA BIOCATALYSTS MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 66 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2021 & 2027
  • EXHIBIT 67 BIOCATALYSTS MARKET IN SAUDI ARABIA 2021-2027 ($ MILLION)
  • EXHIBIT 68 BIOCATALYSTS MARKET IN SOUTH AFRICA 2021-2027 ($ MILLION)
  • EXHIBIT 69 BIOCATALYSTS MARKET IN REST OF MEA 2021-2027 ($ MILLION)
  • EXHIBIT 70 LATIN AMERICA BIOCATALYSTS MARKET 2021-2027 ($ MILLION)
  • EXHIBIT 71 INCREMENTAL GROWTH IN LATIN AMERICA 2021 & 2027
  • EXHIBIT 72 BIOCATALYSTS MARKET IN BRAZIL 2021-2027 ($ MILLION)
  • EXHIBIT 73 BIOCATALYSTS MARKET IN MEXICO 2021-2027 ($ MILLION)
  • EXHIBIT 74 BIOCATALYSTS MARKET IN REST OF MIDDLE EAST & AFRICA 2021-2027 ($ MILLION)
  • EXHIBIT 75 FINANCIAL OVERVIEW ($ BILLION)
  • EXHIBIT 76 SEGMENTAL REVENUE ($ BILLION)
  • EXHIBIT 77 FINANCIAL OVERVIEW ($ BILLION)
  • EXHIBIT 78 SEGMENTAL REVENUE ($ BILLION)
  • EXHIBIT 79 FINANCIAL OVERVIEW ($ BILLION)
  • EXHIBIT 80 FINANCIAL OVERVIEW ($ BILLION)
  • EXHIBIT 81 FINANCIAL OVERVIEW ($ BILLION)

LIST OF TABLES

  • TABLE 1 KEY CAVEATS
  • TABLE 2 CURRENCY CONVERSION 2015-2021
  • TABLE 3 PHARMACEUTICAL INDUSTRY IN EUROPE ($ MILLION)
  • TABLE 4 GLOBAL MEDICINES IN DEVELOPMENT (IN UNITS)
  • TABLE 5 REVENUE OF TOP 10 FOOD & BEVERAGES COMPANIES 2019-2020 ($ BILLION)
  • TABLE 6 CARBOHYDRASES-BASED BIOCATALYSTS MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 7 CARBOHYDRASES-BASED BIOCATALYSTS MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 8 PROTEASES-BASED BIOCATALYSTS MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 9 PROTEASES-BASED BIOCATALYSTS MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 10 POLYMERASES & NUCLEASES BIOCATALYSTS MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 11 POLYMERASES & NUCLEASES BIOCATALYSTS MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 12 LIPASE BIOCATALYSTS MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 13 GLOBAL LIPASE BIOCATALYSTS MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 14 PHYTASES BIOCATALYSTS MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 15 PHYTASES BIOCATALYSTS MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 16 OTHER BIOCATALYSTS MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 17 GLOBAL OTHERS BIOCATALYSTS MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 18 GLOBAL PHARMACEUTICAL BIOCATALYSTS MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 19 GLOBAL PHARMACEUTICAL BIOCATALYSTS MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 20 GLOBAL FOOD & BEVERAGES BIOCATALYSTS MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 21 GLOBAL FOOD & BEVERAGES BIOCATALYSTS MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 22 ANIMAL NUTRITION BIOCATALYSTS MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 23 ANIMAL NUTRITION BIOCATALYSTS MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 24 GLOBAL HOUSEHOLD BIOCATALYSTS MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 25 HOUSEHOLD BIOCATALYSTS MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 26 GLOBAL OTHER BIOCATALYSTS MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 27 GLOBAL OTHER BIOCATALYSTS MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 28 NORTH AMERICA BIOCATALYSTS MARKET BY TYPE 2021-2027 ($ MILLION)
  • TABLE 29 NORTH AMERICA BIOCATALYSTS MARKET BY TYPE 2021-2027 (%)
  • TABLE 30 NORTH AMERICA BIOCATALYSTS MARKET BY END-USER 2021-2027 ($ MILLION)
  • TABLE 31 NORTH AMERICA BIOCATALYSTS MARKET BY END-USER 2021-2027 (%)
  • TABLE 32 BIOCATALYSTS MARKET IN EUROPE BY TYPE 2021-2027 ($ MILLION)
  • TABLE 33 BIOCATALYSTS MARKET IN EUROPE BY TYPE 2021-2027 (%)
  • TABLE 34 BIOCATALYSTS MARKET IN EUROPE BY END-USER 2021-2027 ($ MILLION)
  • TABLE 35 BIOCATALYSTS MARKET IN EUROPE BY END-USER 2021-2027 (%)
  • TABLE 36 APAC BIOCATALYSTS MARKET BY TYPE 2021-2027 ($ MILLION)
  • TABLE 37 APAC BIOCATALYSTS MARKET BY TYPE 2021-2027 (%)
  • TABLE 38 APAC BIOCATALYSTS MARKET BY END-USER 2021-2027 ($ MILLION)
  • TABLE 39 APAC BIOCATALYSTS MARKET BY END-USER 2021-2027 (%)
  • TABLE 40 MIDDLE EAST & AFRICA BIOCATALYSTS MARKET BY TYPE 2021-2027 ($ MILLION)
  • TABLE 41 MIDDLE EAST & AFRICA BIOCATALYSTS MARKET BY TYPE 2021-2027 (%)
  • TABLE 42 MIDDLE EAST & AFRICA BIOCATALYSTS MARKET BY END-USER 2021-2027 ($ MILLION)
  • TABLE 43 MIDDLE EAST & AFRICA BIOCATALYSTS MARKET BY END-USER2021-2027 (%)
  • TABLE 44 LATIN AMERICA BIOCATALYSTS MARKET BY TYPE 2021-2027 ($ MILLION)
  • TABLE 45 LATIN AMERICA BIOCATALYSTS MARKET BY TYPE 2021-2027 (%)
  • TABLE 46 LATIN AMERICA BIOCATALYSTS MARKET BY END-USER 2021-2027 ($ MILLION)
  • TABLE 47 LATIN AMERICA BIOCATALYSTS MARKET BY END-USER 2021-2027 (%)
  • TABLE 48 DUPONT: MAJOR PRODUCT OFFERINGS
  • TABLE 49 BASF SE: MAJOR PRODUCT OFFERINGS
  • TABLE 50 DSM: MAJOR PRODUCT OFFERINGS
  • TABLE 51 AB ENZYMES: MAJOR PRODUCT OFFERINGS
  • TABLE 52 NOVOZYMES: MAJOR PRODUCT OFFERINGS
  • TABLE 53 CHR. HANSEN HOLDING A/S: BUSINESS & FINANCIAL OVERVIEW
  • TABLE 54 CHR HANSEN HOLDING A/S: MAJOR PRODUCT OFFERINGS
  • TABLE 55 CODEXIS: BUSINESS & FINANCIAL OVERVIEW
  • TABLE 56 CODEXIS: MAJOR PRODUCT OFFERINGS
  • TABLE 57 DYADIC INTERNATIONAL INC.: BUSINESS & FINANCIAL OVERVIEW
  • TABLE 58 DYADIC INTERNATIONAL INC.: MAJOR PRODUCT OFFERINGS
  • TABLE 59 AMANO ENZYME INC.: BUSINESS & FINANCIAL OVERVIEW
  • TABLE 60 AMANO ENZYME INC.: MAJOR PRODUCT OFFERINGS
  • TABLE 61 BIOCATALYSTS.: BUSINESS & FINANCIAL OVERVIEW
  • TABLE 62 BIOCATALYSTS: MAJOR PRODUCT OFFERINGS
  • TABLE 63 NATURE BIOSCIENCE: BUSINESS & FINANCIAL OVERVIEW
  • TABLE 64 NATURE BIOSCIENCE PVT LTD.: MAJOR PRODUCT OFFERINGS
  • TABLE 65 JOHNSON MATTHEY: BUSINESS & FINANCIAL OVERVIEW
  • TABLE 66 JOHNSON MATTHEY: MAJOR PRODUCT OFFERINGS
  • TABLE 67 ADVANCED ENZYMES TECHNOLOGIES: BUSINESS & FINANCIAL OVERVIEW
  • TABLE 68 ADVANCED ENZYME TECHNOLOGIES: MAJOR PRODUCT OFFERINGS
  • TABLE 69 ADVANCED ENZYME TECHNOLOGIES: MAJOR PRODUCT OFFERINGS
  • TABLE 70 NUTRITECH: MAJOR PRODUCT OFFERINGS
  • TABLE 71 F. HOFFMANN-LA ROCHE LTD (ROCHE CUSTOMBIOTECH): BUSINESS & FINANCIAL OVERVIEW
  • TABLE 72 F. HOFFMANN-LA ROCHE LTD (ROCHE CUSTOMBIOTECH): MAJOR PRODUCT OFFERINGS
  • TABLE 73 AUMENZYMES: MAJOR PRODUCT OFFERINGS
  • TABLE 74 SOUFFLET GROUP: BUSINESS & FINANCIAL OVERVIEW
  • TABLE 75 SOUFFLET GROUP: MAJOR PRODUCT OFFERINGS
  • TABLE 76 IOSYNTH: BUSINESS & FINANCIAL OVERVIEW
  • TABLE 77 IOSYNTH: MAJOR PRODUCT OFFERINGS
  • TABLE 78 GLOBAL PHARMACEUTICAL BIOCATALYSTS MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 79 GLOBAL PHARMACEUTICAL BIOCATALYSTS MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 80 GLOBAL FOOD & BEVERAGE BIOCATALYSTS MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 81 GLOBAL FOOD & BEVERAGE BIOCATALYSTS MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 82 GLOBAL ANIMAL NUTRITION BIOCATALYSTS MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 83 GLOBAL ANIMAL NUTRITION BIOCATALYSTS MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 84 GLOBAL HOUSEHOLD BIOCATALYSTS MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 85 GLOBAL HOUSEHOLD BIOCATALYSTS MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 86 GLOBAL OTHER BIOCATALYSTS MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 87 GLOBAL OTHER BIOCATALYSTS MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 88 GLOBAL CARBOHYDRASE BIOCATALYSTS MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 89 GLOBAL CARBOHYDRASE BIOCATALYSTS MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 90 GLOBAL PROTEASE BIOCATALYSTS MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 91 GLOBAL PROTEASE BIOCATALYSTS MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 92 GLOBAL POLYMERASES & NUCLEASES BIOCATALYSTS MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 93 GLOBAL POLYMERASES & NUCLEASES BIOCATALYSTS MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 94 GLOBAL LIPASE BIOCATALYSTS MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 95 GLOBAL LIPASE BIOCATALYSTS MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 96 GLOBAL PHYTASES BIOCATALYSTS MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 97 GLOBAL PHYTASES BIOCATALYSTS MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 98 GLOBAL OTHER BIOCATALYSTS MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)
  • TABLE 99 GLOBAL OTHER BIOCATALYSTS MARKET BY GEOGRAPHY 2021-2027 (%)
  • TABLE 100 GLOBAL NORTH AMERICA BIOCATALYSTS MARKET BY TYPE 2021-2027 ($ MILLION)
  • TABLE 101 GLOBAL NORTH AMERICA BIOCATALYSTS MARKET BY TYPE 2021-2027 (%)
  • TABLE 102 GLOBAL NORTH AMERICA BIOCATALYSTS MARKET BY END-USER 2021-2027 ($ MILLION)
  • TABLE 103 GLOBAL NORTH AMERICA BIOCATALYSTS MARKET BY END-USER 2021-2027 (%)
  • TABLE 104 GLOBAL EUROPE BIOCATALYSTS MARKET BY TYPE 2021-2027 ($ MILLION)
  • TABLE 105 GLOBAL EUROPE BIOCATALYSTS MARKET BY TYPE 2021-2027 (%)
  • TABLE 106 GLOBAL EUROPE BIOCATALYSTS MARKET BY END-USER 2021-2027 ($ MILLION)
  • TABLE 107 GLOBAL EUROPE BIOCATALYSTS MARKET BY END-USE 2021-2027 (%)
  • TABLE 108 GLOBAL APAC BIOCATALYSTS MARKET BY TYPE 2021-2027 ($ MILLION)
  • TABLE 109 GLOBAL APAC BIOCATALYSTS MARKET BY TYPE 2021-2027 (%)
  • TABLE 110 GLOBAL APAC BIOCATALYSTS MARKET BY END-USER 2021-2027 ($ MILLION)
  • TABLE 111 GLOBAL APAC BIOCATALYSTS MARKET BY END-USER 2021-2027 (%)
  • TABLE 112 GLOBAL MIDDLE EAST & AFRICA BIOCATALYSTS MARKET BY TYPE 2021-2027 ($ MILLION)
  • TABLE 113 GLOBAL MIDDLE EAST & AFRICA BIOCATALYSTS MARKET BY TYPE 2021-2027 (%)
  • TABLE 114 GLOBAL MIDDLE EAST & AFRICA BIOCATALYSTS MARKET BY END-USER 2021-2027 ($ MILLION)
  • TABLE 115 GLOBAL MIDDLE EAST & AFRICA BIOCATALYSTS MARKET BY END-USER 2021-2027 (%)
  • TABLE 116 GLOBAL LATIN AMERICA BIOCATALYSTS MARKET BY TYPE 2021-2027 ($ MILLION)
  • TABLE 117 GLOBAL LATIN AMERICA BIOCATALYSTS MARKET BY TYPE 2021-2027 (%)
  • TABLE 118 GLOBAL LATIN AMERICA BIOCATALYSTS MARKET BY END-USER 2021-2027 ($ MILLION)
  • TABLE 119 GLOBAL LATIN AMERICA BIOCATALYSTS MARKET BY END-USER 2021-2027 (%)